Company / Named in our posts
Akari Therapeutics, Plc.
Follow Akari Therapeutics, PlcAkari Therapeutics is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.[1]
01Deal
Deals on Carrywatch
Every deal that names Akari Therapeutics, Plc, and its role in each.
Akari Therapeutics, Plc / Peak Bio, Inc.
Akari Therapeutics, Plc completes purchase of Peak Bio, Inc.
See deal detailsDeal Web
Akari Therapeutics, Plc and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
6 fiscal years of figures as Akari Therapeutics, Plc reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02SEC EDGAR company record for Akari Therapeutics Plc
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Akari Therapeutics, Plc:
- P01